Entera Bio's Convertible Note Round

Entera Bio raised a round of funding on July 24, 2016.

Entera Bio is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the…

Articles about Entera Bio's Convertible Note Round: